Clinical Provider Quick Tips

Addressing Substance Use in Primary Care Settings

What You Need to Know

Quick Tips & Guides

Working with Individuals who use Cocaine and Methamphetamine: Reordering Priorities

Presenter: Richard Rawson

Quick Tips
  • Methamphetamine Factsheet (PDF)
  • Methamphetamine Patient Education (PDF)
Guides
  • Bureau of Substance Addiction Services (BSAS); Integration of Care for People who Use Stimulants into Substance Use (PDF)
  • Substance Abuse and Mental Health Services Administration (SAMHSA): Treatment of Stimulant Use Disorders, Evidence-Based Resource Guide Series (PDF)
  • Substance Abuse and Mental Health Services Administration (SAMHSA). Prescription Stimulant Misuse and Prevention Among Youth and Young Adults (PDF)
Articles
  • Dropout Rates of In-person Psychosocial Substance Use Disorder Treatments (2019) (PDF)
  • Interest in Reducing Methamphetamine and Opioid Use Among Syringe Services Program Participants in Washington State (2020) (PDF)
  • Neurobiology, Clinical Presentation, and Treatment (2020) (PDF)

Clinical Recognition of Stimulant Use Disorder (StUD)... Including Methamphetamine

Presenter: Frances Southwick

Quick Tips
  • Single Question SUD Screener (PDF)
Guides

Primary Care/Harm Reduction for People Who Use Stimulants

Presenter: Candy Stockton-Joreteg

Quick Tips
  • Safer Drug Use (PDF)
Guides
  • Comprehensive Primary Care Guide for Patients who Drink Alcohol and Use Drugs (PDF)

Getting to the Good Part, How to Take an Engaging Substance Use History

Presenter: La Donna Porter

Quick Tips
  • Comprehensive SUD History Assessment (PDF)
Guides
  • PCSS Course: Principles of Motivational Interviewing: Useful for Primary Care Providers (1-hr, 1.0 CME Version)
Articles
  • Ten Things that Motivational Interviewing Is Not (2009) (PDF)

Motivational Interviewing Strategies to Help Increase Engagement in Care

Presenter: Joy Chudzynski

Quick Tips
  • Stages of Change: Primary Tasks (PDF)
  • OARS-MI Processes-Readiness Ruler Card (PDF)
  • Ask-Tell-Ask Approach (PDF)
Guides
  • SAMHSA TIP 35: Enhancing Motivation for Change in SUD Treatment (PDF)
  • Motivational Interviewing: An Introduction (17-min Video)
Articles
  • Motivational interviewing with Primary Care Populations: A Systematic Review and Meta-Analysis (2014) (PDF)

Methamphetamine Use Disorder: Mental Health Sequela and Treatment in Primary Care

Presenter: Joe Sepulveda

Quick Tips
  • Methamphetamine Psychosis (PDF)
Guides
  • SAMHSA TIP 33: Treatment for Stimulant Use Disorders (PDF)
  • Guidelines for Physicians Working in California Opioid Treatment Programs (CSAM) (PDF)
  • Unhealthy Alcohol and Drug Use, Adult, Primary Care Clinical Practice Guideline (PDF)
Articles
  • The Profile of Psychiatric Symptoms Exacerbated by Methamphetamine Use (2016) (PDF)
  • Substance-Induced Psychoses: An Updated Literature Review (2021) (PDF)
  • Methamphetamine‐Associated Psychosis: Clinical Presentation, Biological Basis, and Treatment Options (2019) (PDF)
  • Pharmacotherapy Treatment of Stimulant Use Disorder (2021) (PDF)
  • Aripiprazole and Risperidone for Treatment of Methamphetamine Associated Psychosis in Chinese Patients (2016) (PDF)
  • Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex with Men (2019) (PDF)
  • Bupropion and Naltrexone in Methamphetamine Use Disorder (2021) (PDF)

Equity and Justice in Substance Use Disorder Treatment

Presenter: H. Westley Clark

Quick Tips
  • Words Matter: Terms to Use to Remove Bias from Your Language (PDF)
  • Racial Disparities in Access to MAT in California (PDF)
Guides
  • Annual National Report: Key Substance Use and Mental Health Indicators in the United States (Graphics from the Key Findings Report, SAMHSA 2022) (PDF)
  • Full Report: Key substance use and mental health indicators in the United States: Results from the 2021 National Survey on Drug Use and Health (SAMHSA 2022) (PDF)
Articles
  • Drug Overdose Deaths in the United States, 1999-2020 (2021) (PDF)
  • Buprenorphine Treatment Divide by Race/ethnicity and Payment (2019) (PDF)

The US Overdose Crisis: Rapid Shifts in Fentanyl and Novel Synthetic Substances

Presenter: Joseph Friedman

Quick Tips
  • Fentanyl: Drug Fact Sheet-DEA (PDF)
  • The Facts about Fentanyl-CDC (PDF)
  • One Pill Can Kill: Overview and Key Results (PDF)
Guides
  • Prescription Stimulant Misuse and Prevention Among Youth and Young Adults (SAMHSA 2021) (PDF)
Articles
  • Changing Dynamics of the Drug Overdose Epidemic in the United States from 1979 through 2016 (2018) (PDF)
  • Drug Checking in British Columbia (2021) (PDF)
  • Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis (2022) (PDF)
  • Trends in Drug Overdose Deaths Among US Adolescents, January 2010 to June 2021 (2022) (PDF)

What The Fentanyl! Understanding Fentanyl from the Primary Care Setting

Presenter: Arianna Campbell

Quick Tips
  • Prescription Opioids and Heroin-Patient Education (PDF)
  • Naloxone: How to use Naloxone to Reverse an Overdose- Patient Education (PDF)
  • Fentanyl FAQ for Providers (PDF)
  • How to Recognize and Respond to an Overdose-Patient Education (PDF)
Guides
  • Guide to Naloxone Distribution (PDF)
Articles
  • Mortality Risk During and After Opioid Substitution Treatment: Systematic Review and Meta-Analysis of Cohort Studies (2017) (PDF)
  • Mortality Associated with Time In and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study (2017) (PDF)
  • Impact of Fentanyl Use on Buprenorphine Treatment Retention and Opioid Abstinence (2019) (PDF)

Buprenorphine for Patients Using Fentanyl

Presenter: Reb Close

Quick Tips
  • Buprenorphine Quick Start Guide-Providers (PDF)
  • Buprenorphine Self-Start Guide (PDF)
  • Starting Buprenorphine with Microdosing and Cross Tapering (PDF)
  • Clinical Opiate Withdrawal Scale (COWS) (PDF)
Guides
  • Buprenorphine – Frequently Asked Questions (PDF)
  • MAT Make it Happen: A Clinical Introduction to MAT for OUD (PDF)
  • Back to Basics: Buprenorphine 101 (38 min Video)
Articles
  • High-Dose Buprenorphine Initiation in the Emergency Department Among Patients Using Fentanyl and Other Opioids (PDF)
  • A Neuropharmacological Model to Explain Buprenorphine Induction Challenges (2022) (PDF)

This series is sponsored by the Department of Healthcare Services in California through the SAMSHA State Opioid Response Grants. All information in the presentations are generated by the presenters and do not reflect the opinions of CA DHCS.